BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 18536573)

  • 1. Retinoic acid receptors, hematopoiesis and leukemogenesis.
    Collins SJ
    Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid signaling in myelopoiesis.
    Drumea K; Yang ZF; Rosmarin A
    Curr Opin Hematol; 2008 Jan; 15(1):37-41. PubMed ID: 18043244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
    Randolph TR
    Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission.
    Zhu J; Lallemand-Breitenbach V; de Thé H
    Oncogene; 2001 Oct; 20(49):7257-65. PubMed ID: 11704854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?
    Minucci S; Nervi C; Lo Coco F; Pelicci PG
    Oncogene; 2001 May; 20(24):3110-5. PubMed ID: 11420727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients.
    Cornic M; Delva L; Guidez F; Balitrand N; Degos L; Chomienne C
    Cancer Res; 1992 Jun; 52(12):3329-34. PubMed ID: 1317749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.
    He LZ; Merghoub T; Pandolfi PP
    Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.
    Puccetti E; Ruthardt M
    Leukemia; 2004 Jul; 18(7):1169-75. PubMed ID: 15103387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias.
    Merghoub T; Gurrieri C; Piazza F; Pandolfi PP
    Blood Cells Mol Dis; 2001; 27(1):231-48. PubMed ID: 11358384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.
    Meani N; Minardi S; Licciulli S; Gelmetti V; Coco FL; Nervi C; Pelicci PG; Müller H; Alcalay M
    Oncogene; 2005 May; 24(20):3358-68. PubMed ID: 15735696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
    Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
    Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
    Tussié-Luna MI; Rozo L; Roy AL
    Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic reversion in acute promyelocytic leukemia.
    Degos L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):511-5. PubMed ID: 1667950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L
    J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?].
    de Thé H
    Bull Acad Natl Med; 1998; 182(1):63-71. PubMed ID: 9622932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of differentiation of human leukemia cells].
    Kizaki M; Nakajima H; Ikeda Y
    Hum Cell; 1992 Jun; 5(2):103-9. PubMed ID: 1382572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.